Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: a prospective test negative case–control study
-
Published:2023-02
Issue:
Volume:25
Page:100552
-
ISSN:2666-7762
-
Container-title:The Lancet Regional Health - Europe
-
language:en
-
Short-container-title:The Lancet Regional Health - Europe
Author:
Chatzilena Anastasia, Hyams Catherine, Challen Rob, Marlow Robin, King Jade, Adegbite David, Kinney Jane, Clout Madeleine, Maskell Nick, Oliver Jennifer, Danon Leon, Finn AdamORCID, Morley Anna, Langdon Amelia, Turner Anabella, Mattocks Anya, Osborne Bethany, Grimes Charli, Mitchell Claire, Bridgeman Emma, Scott Emma, Perkins Fiona, Bayley Francesca, Ruffino Gabriella, Valentine Gabriella, Tilzey Grace, Kellett Wright Johanna, Brzezinska Julia, Cloake Julie, Milutinovic Katarina, Helliker Kate, Maughan Katie, Fox Kazminder, Minou Konstantina, Ward Lana, Fleming Leah, Morrison Leigh, Smart Lily, Wright Louise, Grimwood Lucy, Bellavia Maddalena, Vasquez Marianne, Garcia Gonzalez Maria, Jeenes-Flanagan Milo, Chang Natalie, Grace Niall, Manning Nicola, Griffiths Oliver, Croxford Pip, Sequenza Peter, Lazarus Rajeka, Walters Rhian, Marlow Robin, Heath Robyn, Antico Rupert, Nammuni Arachchge Sandi, Suppiah Seevakumar, Mona Taslima, Riaz Tawassal, Mackay Vicki, Maseko Zandile, Taylor Zoe, Friedrich Zsolt, Szasz-Benczur Zsuzsa
Subject
Health Policy,Oncology,Internal Medicine
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|